NCT06392529View on ClinicalTrials.gov

Efficacy of Voriconazole Loaded Spanlastics Gel Versus Clotriamazole Cream on Treating Vulvovaginal Candidasis

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

June 15, 2024

Study Completion Date

June 30, 2024

Conditions
Breast Cancer
Interventions
DRUG

Voriconazole Powder

The drug will be topically applied for vagina of patients suffering from vaginal Candidasis albican

Trial Locations (1)

Unknown

Beni-Suef University Teaching Hospital, Giza

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT06392529 - Efficacy of Voriconazole Loaded Spanlastics Gel Versus Clotriamazole Cream on Treating Vulvovaginal Candidasis | Biotech Hunter | Biotech Hunter